Literature DB >> 1473003

The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids.

G A Lambert1, A J Lowy, P M Boers, H Angus-Leppan, A S Zagami.   

Abstract

The effects of ergot alkaloids on field potentials and unit responses produced in the upper cervical spinal cord by stimulation of the superior sagittal sinus (SSS) were examined in 57 anesthetized cats. Electrical stimulation of the SSS produced field potentials and single-unit responses at latencies of 5-20 ms. Field potentials were abolished by section of the first division of the trigeminal nerve but were unaffected or increased by section of the upper cervical nerves. Field potentials were reduced or abolished by intravenous injection of ergotamine or dihydroergotamine (DHE). The evoked response of 41 units (34.4%) were suppressed by either i.v. or iontophoretic administration of ergotamine, DHE or ergometrine. The results suggest that ergot alkaloids exert an effect at a spinal cord relay centre which receives trigeminally mediated input from cranial blood vessels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1473003     DOI: 10.1016/0006-8993(92)91489-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  [Animal models and their results in relation to the therapy of migraine].

Authors:  H Kaube; V Limmroth
Journal:  Schmerz       Date:  1996-06-17       Impact factor: 1.107

Review 3.  Preclinical neuropharmacology of naratriptan.

Authors:  Geoffrey A Lambert
Journal:  CNS Drug Rev       Date:  2005

4.  The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission.

Authors:  G A Lambert; J B Davis; J M Appleby; B A Chizh; K L Hoskin; A S Zagami
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-08-19       Impact factor: 3.000

5.  Lignocaine and headache: an electrophysiological study in the cat with supporting clinical observations in man.

Authors:  H Kaube; K L Hoskin; P J Goadsby
Journal:  J Neurol       Date:  1994-06       Impact factor: 4.849

6.  Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex.

Authors:  R J Storer; S Akerman; P J Goadsby
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

7.  Acute migraine therapy: new drugs and new approaches.

Authors:  Teshamae S Monteith; Peter J Goadsby
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

8.  Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology.

Authors:  Carolyn Bernstein; Rami Burstein
Journal:  J Clin Neurol       Date:  2012-06-29       Impact factor: 3.077

Review 9.  Animal models of migraine and experimental techniques used to examine trigeminal sensory processing.

Authors:  Andrea M Harriott; Lauren C Strother; Marta Vila-Pueyo; Philip R Holland
Journal:  J Headache Pain       Date:  2019-08-29       Impact factor: 7.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.